{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T12:35:55Z","timestamp":1775565355789,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Jpn J Radiol"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s11604-024-01635-y","type":"journal-article","created":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T07:07:36Z","timestamp":1722496056000},"page":"1381-1391","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Review of whole-body magnetic resonance imaging in multiple myeloma"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3840-7637","authenticated-orcid":false,"given":"Teresa","family":"Perillo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Giorgio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arianna","family":"Fico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianna","family":"Perrotta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonietta","family":"Serino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renato","family":"Cuocolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Manto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,1]]},"reference":[{"key":"1635_CR1","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1046\/j.1365-2141.2003.04355.x","volume":"121","author":"International Myeloma Working Group","year":"2003","unstructured":"International Myeloma Working Group. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol. 2003;121:749\u201357.","journal-title":"Br J Haematol"},{"key":"1635_CR2","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4065\/78.1.21","volume":"78","author":"RA Kyle","year":"2003","unstructured":"Kyle RA, Gertz MA, Witzig TE, et al. Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc. 2003;78:21\u201333. https:\/\/doi.org\/10.4065\/78.1.21.","journal-title":"Mayo Clin Proc"},{"key":"1635_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1148\/radiol.2311020452","volume":"231","author":"EJC Angtuaco","year":"2004","unstructured":"Angtuaco EJC, Fassas ABT, Walker R, et al. Multiple myeloma: clinical review and diagnostic imaging. Radiology. 2004;231:11\u201323. https:\/\/doi.org\/10.1148\/radiol.2311020452.","journal-title":"Radiology"},{"key":"1635_CR4","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1158\/1078-0432.CCR-10-1822","volume":"17","author":"O Landgren","year":"2011","unstructured":"Landgren O, Kyle RA, Rajkumar SV. From myeloma precursor disease to multiple myeloma: new diagnostic concepts and opportunities for early intervention. Clin Cancer Res. 2011;17:1243\u201352. https:\/\/doi.org\/10.1158\/1078-0432.CCR-10-1822.","journal-title":"Clin Cancer Res"},{"key":"1635_CR5","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.mric.2018.06.006","volume":"26","author":"C Messiou","year":"2018","unstructured":"Messiou C, Kaiser M. Whole-Body Imaging in Multiple myeloma. Magn Reson Imaging Clin N Am. 2018;26:509\u201325. https:\/\/doi.org\/10.1016\/j.mric.2018.06.006.","journal-title":"Magn Reson Imaging Clin N Am"},{"key":"1635_CR6","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1200\/JCO.1993.11.7.1311","volume":"11","author":"LA Moulopoulos","year":"1993","unstructured":"Moulopoulos LA, Dimopoulos MA, Weber D, et al. Magnetic resonance imaging in the staging of solitary plasmacytoma of bone. JCO. 1993;11:1311\u20135. https:\/\/doi.org\/10.1200\/JCO.1993.11.7.1311.","journal-title":"JCO"},{"key":"1635_CR7","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1148\/radiol.2019181949","volume":"291","author":"C Messiou","year":"2019","unstructured":"Messiou C, Hillengass J, Delorme S, et al. Guidelines for acquisition, interpretation, and reporting of whole-body MRI in Myeloma: Myeloma Response Assessment and Diagnosis System (MY-RADS). Radiology. 2019;291:5\u201313. https:\/\/doi.org\/10.1148\/radiol.2019181949.","journal-title":"Radiology"},{"key":"1635_CR8","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.3109\/10428194.2012.740559","volume":"54","author":"J Hillengass","year":"2013","unstructured":"Hillengass J, Landgren O. Challenges and opportunities of novel imaging techniques in monoclonal plasma cell disorders: imaging \u201cearly myeloma.\u201d Leuk Lymphoma. 2013;54:1355\u201363. https:\/\/doi.org\/10.3109\/10428194.2012.740559.","journal-title":"Leuk Lymphoma"},{"key":"1635_CR9","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1111\/j.1365-2141.2011.08658.x","volume":"153","author":"J Hillengass","year":"2011","unstructured":"Hillengass J, B\u00e4uerle T, Bartl R, et al. Diffusion-weighted imaging for non-invasive and quantitative monitoring of bone marrow infiltration in patients with monoclonal plasma cell disease: a comparative study with histology. Br J Haematol. 2011;153:721\u20138. https:\/\/doi.org\/10.1111\/j.1365-2141.2011.08658.x.","journal-title":"Br J Haematol"},{"key":"1635_CR10","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1148\/radiol.13131529","volume":"271","author":"SL Giles","year":"2014","unstructured":"Giles SL, Messiou C, Collins DJ, et al. Whole-body diffusion-weighted mr imaging for assessment of treatment response in myeloma. Radiology. 2014;271:785\u201394. https:\/\/doi.org\/10.1148\/radiol.13131529.","journal-title":"Radiology"},{"key":"1635_CR11","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1038\/leu.2015.338","volume":"30","author":"C Pawlyn","year":"2016","unstructured":"Pawlyn C, Fowkes L, Otero S, et al. Whole-body diffusion-weighted MRI: a new gold standard for assessing disease burden in patients with multiple myeloma? Leukemia. 2016;30:1446\u20138. https:\/\/doi.org\/10.1038\/leu.2015.338.","journal-title":"Leukemia"},{"key":"1635_CR12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/leu.2008.291","volume":"23","author":"RA Kyle","year":"2009","unstructured":"Kyle RA, Rajkumar SV. Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma. Leukemia. 2009;23:3\u20139. https:\/\/doi.org\/10.1038\/leu.2008.291.","journal-title":"Leukemia"},{"key":"1635_CR13","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/hon.2586","volume":"37","author":"SV Rajkumar","year":"2019","unstructured":"Rajkumar SV. Multiple myeloma: every year a new standard? Hematol Oncol. 2019;37:62\u20135. https:\/\/doi.org\/10.1002\/hon.2586.","journal-title":"Hematol Oncol"},{"key":"1635_CR14","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.3348\/kjr.2020.0886","volume":"22","author":"K Lee","year":"2021","unstructured":"Lee K, Kim KW, Ko Y, et al. Comprehensive updates in the role of imaging for multiple myeloma management based on recent International Guidelines. Korean J Radiol. 2021;22:1497. https:\/\/doi.org\/10.3348\/kjr.2020.0886.","journal-title":"Korean J Radiol"},{"key":"1635_CR15","doi-asserted-by":"publisher","first-page":"20180768","DOI":"10.1259\/bjr.20180768","volume":"92","author":"T Barwick","year":"2019","unstructured":"Barwick T, Bretsztajn L, Wallitt K, et al. Imaging in myeloma with focus on advanced imaging techniques. BJR. 2019;92:20180768. https:\/\/doi.org\/10.1259\/bjr.20180768.","journal-title":"BJR"},{"key":"1635_CR16","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1148\/rg.2019180096","volume":"39","author":"AG Ormond Filho","year":"2019","unstructured":"Ormond Filho AG, Carneiro BC, Pastore D, et al. Whole-body imaging of multiple myeloma: diagnostic criteria. Radiographics. 2019;39:1077\u201397. https:\/\/doi.org\/10.1148\/rg.2019180096.","journal-title":"Radiographics"},{"key":"1635_CR17","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1148\/rg.352140112","volume":"35","author":"R Ferraro","year":"2015","unstructured":"Ferraro R, Agarwal A, Martin-Macintosh EL, et al. MR imaging and PET\/CT in diagnosis and management of multiple myeloma. Radiographics. 2015;35:438\u201354. https:\/\/doi.org\/10.1148\/rg.352140112.","journal-title":"Radiographics"},{"key":"1635_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.825394","volume":"12","author":"A Guha","year":"2022","unstructured":"Guha A, Vijan A, Agarwal U, et al. Imaging for plasma cell dyscrasias: What, When, and How? Front Oncol. 2022;12: 825394. https:\/\/doi.org\/10.3389\/fonc.2022.825394.","journal-title":"Front Oncol"},{"key":"1635_CR19","doi-asserted-by":"publisher","first-page":"e206","DOI":"10.1016\/S1470-2045(17)30189-4","volume":"18","author":"M Cavo","year":"2017","unstructured":"Cavo M, Terpos E, Nanni C, et al. Role of 18F-FDG PET\/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group. Lancet Oncol. 2017;18:e206\u201317. https:\/\/doi.org\/10.1016\/S1470-2045(17)30189-4.","journal-title":"Lancet Oncol"},{"key":"1635_CR20","doi-asserted-by":"publisher","first-page":"2890","DOI":"10.1007\/s00330-018-5330-5","volume":"28","author":"CH Suh","year":"2018","unstructured":"Suh CH, Yun SJ, Jin W, et al. ADC as a useful diagnostic tool for differentiating benign and malignant vertebral bone marrow lesions and compression fractures: a systematic review and meta-analysis. Eur Radiol. 2018;28:2890\u2013902. https:\/\/doi.org\/10.1007\/s00330-018-5330-5.","journal-title":"Eur Radiol"},{"key":"1635_CR21","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1038\/leu.2009.89","volume":"23","author":"M Dimopoulos","year":"2009","unstructured":"Dimopoulos M, Terpos E, Comenzo RL, et al. International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma. Leukemia. 2009;23:1545\u201356. https:\/\/doi.org\/10.1038\/leu.2009.89.","journal-title":"Leukemia"},{"key":"1635_CR22","first-page":"479","volume":"5","author":"C Sachpekidis","year":"2015","unstructured":"Sachpekidis C, Mosebach J, Freitag MT, et al. Application of (18)F-FDG PET and diffusion weighted imaging (DWI) in multiple myeloma: comparison of functional imaging modalities. Am J Nucl Med Mol Imag. 2015;5:479\u201392.","journal-title":"Am J Nucl Med Mol Imag"},{"key":"1635_CR23","doi-asserted-by":"publisher","first-page":"602","DOI":"10.2214\/AJR.21.26381","volume":"218","author":"S Rama","year":"2022","unstructured":"Rama S, Suh CH, Kim KW, et al. Comparative performance of whole-body MRI and FDG PET\/CT in evaluation of multiple myeloma treatment response: systematic review and meta-analysis. Am J Roentgenol. 2022;218:602\u201313. https:\/\/doi.org\/10.2214\/AJR.21.26381.","journal-title":"Am J Roentgenol"},{"key":"1635_CR24","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.crad.2021.04.001","volume":"76","author":"JM Winfield","year":"2021","unstructured":"Winfield JM, Blackledge MD, Tunariu N, et al. Whole-body MRI: a practical guide for imaging patients with malignant bone disease. Clin Radiol. 2021;76:715\u201327. https:\/\/doi.org\/10.1016\/j.crad.2021.04.001.","journal-title":"Clin Radiol"},{"key":"1635_CR25","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.2214\/AJR.09.7069","volume":"193","author":"PG Swartz","year":"2009","unstructured":"Swartz PG, Roberts CC. Radiological reasoning: bone marrow changes on MRI. Am J Roentgenol. 2009;193:S1\u20134. https:\/\/doi.org\/10.2214\/AJR.09.7069.","journal-title":"Am J Roentgenol"},{"key":"1635_CR26","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s002560050423","volume":"27","author":"BC Vande Berg","year":"1998","unstructured":"Vande Berg BC, Malghem J, Lecouvet FE, Maldague B. Magnetic resonance imaging of the normal bone marrow. Skeletal Radiol. 1998;27:471\u201383. https:\/\/doi.org\/10.1007\/s002560050423.","journal-title":"Skeletal Radiol"},{"key":"1635_CR27","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1002\/jmri.25769","volume":"47","author":"DC Karampinos","year":"2018","unstructured":"Karampinos DC, Ruschke S, Dieckmeyer M, et al. Quantitative MRI and spectroscopy of bone marrow. Magn Reson Imag. 2018;47:332\u201353. https:\/\/doi.org\/10.1002\/jmri.25769.","journal-title":"Magn Reson Imag"},{"key":"1635_CR28","doi-asserted-by":"publisher","unstructured":"Caranci F, Tedeschi E, Ugga L, et al. Magnetic Resonance Imaging correlates of benign and malignant alterations of the spinal bone marrow. Acta Biomed 2018;89:18\u201333. https:\/\/doi.org\/10.23750\/abm.v89i1-S.7008","DOI":"10.23750\/abm.v89i1-S.7008"},{"key":"1635_CR29","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1002\/jmri.1105","volume":"13","author":"Y Nonomura","year":"2001","unstructured":"Nonomura Y, Yasumoto M, Yoshimura R, et al. Relationship between bone marrow cellularity and apparent diffusion coefficient. Magn Reson Imag. 2001;13:757\u201360. https:\/\/doi.org\/10.1002\/jmri.1105.","journal-title":"Magn Reson Imag"},{"key":"1635_CR30","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/bjh.13509","volume":"171","author":"C Messiou","year":"2015","unstructured":"Messiou C, Kaiser M. Whole body diffusion weighted MRI \u2013 a new view of myeloma. Br J Haematol. 2015;171:29\u201337. https:\/\/doi.org\/10.1111\/bjh.13509.","journal-title":"Br J Haematol"},{"key":"1635_CR31","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1053\/j.ro.2009.01.003","volume":"44","author":"MA Jacobs","year":"2009","unstructured":"Jacobs MA, Pan L, Macura KJ. Whole-body diffusion-weighted and proton imaging: a review of this emerging technology for monitoring metastatic cancer. Semin Roentgenol. 2009;44:111\u201322. https:\/\/doi.org\/10.1053\/j.ro.2009.01.003.","journal-title":"Semin Roentgenol"},{"key":"1635_CR32","doi-asserted-by":"publisher","first-page":"5859","DOI":"10.1002\/cam4.4136","volume":"10","author":"A Belotti","year":"2021","unstructured":"Belotti A, Ribolla R, Cancelli V, et al. Predictive role of diffusion-weighted whole-body MRI (DW-MRI) imaging response according to MY-RADS criteria after autologous stem cell transplantation in patients with multiple myeloma and combined evaluation with MRD assessment by flow cytometry. Cancer Med. 2021;10:5859\u201365. https:\/\/doi.org\/10.1002\/cam4.4136.","journal-title":"Cancer Med"},{"key":"1635_CR33","doi-asserted-by":"publisher","first-page":"109403","DOI":"10.1016\/j.ejrad.2020.109403","volume":"133","author":"A Paternain","year":"2020","unstructured":"Paternain A, Garc\u00eda-Velloso MJ, Rosales JJ, et al. The utility of ADC value in diffusion-weighted whole-body MRI in the follow-up of patients with multiple myeloma. Correlation study with 18F-FDG PET-CT. Eur J Radiol. 2020;133:109403. https:\/\/doi.org\/10.1016\/j.ejrad.2020.109403.","journal-title":"Eur J Radiol"},{"key":"1635_CR34","doi-asserted-by":"publisher","first-page":"e1198","DOI":"10.1259\/bjr\/52759767","volume":"85","author":"C Messiou","year":"2012","unstructured":"Messiou C, Giles S, Collins DJ, et al. Assessing response of myeloma bone disease with diffusion-weighted MRI. BJR. 2012;85:e1198\u2013203. https:\/\/doi.org\/10.1259\/bjr\/52759767.","journal-title":"BJR"},{"key":"1635_CR35","doi-asserted-by":"publisher","first-page":"310","DOI":"10.2214\/AJR.21.26534","volume":"218","author":"H Dong","year":"2022","unstructured":"Dong H, Huang W, Ji X, et al. Prediction of early treatment response in multiple myeloma using MY-RADS total burden score, ADC, and fat fraction from whole-body MRI: impact of anemia on predictive performance. Am J Roentgenol. 2022;218:310\u20139. https:\/\/doi.org\/10.2214\/AJR.21.26534.","journal-title":"Am J Roentgenol"},{"key":"1635_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0180562","volume":"12","author":"TJP Bray","year":"2017","unstructured":"Bray TJP, Singh S, Latifoltojar A, et al. Diagnostic utility of whole body Dixon MRI in multiple myeloma: a multi-reader study. PLoS One. 2017;12: e0180562. https:\/\/doi.org\/10.1371\/journal.pone.0180562.","journal-title":"PLoS One"},{"key":"1635_CR37","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1093\/jnci\/92.24.2029","volume":"92","author":"TL Chenevert","year":"2000","unstructured":"Chenevert TL. Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors. J Natl Cancer Inst. 2000;92:2029\u201336. https:\/\/doi.org\/10.1093\/jnci\/92.24.2029.","journal-title":"J Natl Cancer Inst"},{"key":"1635_CR38","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.mric.2007.03.002","volume":"15","author":"F Alyas","year":"2007","unstructured":"Alyas F, Saifuddin A, Connell D. MR imaging evaluation of the bone marrow and marrow infiltrative disorders of the lumbar spine. Magn Reson Imag Clin N Am. 2007;15:199\u2013219. https:\/\/doi.org\/10.1016\/j.mric.2007.03.002.","journal-title":"Magn Reson Imag Clin N Am"},{"key":"1635_CR39","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s13244-016-0492-7","volume":"7","author":"JC Dutoit","year":"2016","unstructured":"Dutoit JC, Verstraete KL. MRI in multiple myeloma: a pictorial review of diagnostic and post-treatment findings. Insights Imag. 2016;7:553\u201369. https:\/\/doi.org\/10.1007\/s13244-016-0492-7.","journal-title":"Insights Imag"},{"key":"1635_CR40","doi-asserted-by":"publisher","first-page":"20200312","DOI":"10.1259\/bjr.20200312","volume":"93","author":"M Hameed","year":"2020","unstructured":"Hameed M, Sandhu A, Soneji N, et al. Pictorial review of whole body MRI in myeloma: emphasis on diffusion-weighted imaging. BJR. 2020;93:20200312. https:\/\/doi.org\/10.1259\/bjr.20200312.","journal-title":"BJR"},{"key":"1635_CR41","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41408-022-00643-3","volume":"12","author":"J Blad\u00e9","year":"2022","unstructured":"Blad\u00e9 J, Beksac M, Caers J, et al. Extramedullary disease in multiple myeloma: a systematic literature review. Blood Cancer J. 2022;12:45. https:\/\/doi.org\/10.1038\/s41408-022-00643-3.","journal-title":"Blood Cancer J"},{"key":"1635_CR42","doi-asserted-by":"publisher","first-page":"250","DOI":"10.4110\/in.2017.17.4.250","volume":"17","author":"K Batsukh","year":"2017","unstructured":"Batsukh K, Lee S-E, Min GJ, et al. Distinct clinical outcomes between paramedullary and extramedullary lesions in newly diagnosed multiple myeloma. Immune Netw. 2017;17:250. https:\/\/doi.org\/10.4110\/in.2017.17.4.250.","journal-title":"Immune Netw"},{"key":"1635_CR43","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1111\/bjh.17338","volume":"194","author":"L Rosi\u00f1ol","year":"2021","unstructured":"Rosi\u00f1ol L, Beksac M, Zamagni E, et al. Expert review on soft-tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations. Br J Haematol. 2021;194:496\u2013507. https:\/\/doi.org\/10.1111\/bjh.17338.","journal-title":"Br J Haematol"},{"key":"1635_CR44","doi-asserted-by":"publisher","unstructured":"Ruiz Santiago F, L\u00e1inez Ramos-Bossini AJ, W\u00e1ng YXJ, et al. The value of magnetic resonance imaging and computed tomography in the study of spinal disorders. Quant Imag Med Surg 2022;12:3947\u20133986. https:\/\/doi.org\/10.21037\/qims-2022-04","DOI":"10.21037\/qims-2022-04"},{"key":"1635_CR45","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1007\/s002560100390","volume":"30","author":"V Baudrez","year":"2001","unstructured":"Baudrez V, Galant C, Vande Berg BC. Benign vertebral hemangioma: MR-histological correlation. Skeletal Radiol. 2001;30:442\u20136. https:\/\/doi.org\/10.1007\/s002560100390.","journal-title":"Skeletal Radiol"},{"key":"1635_CR46","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1007\/s00330-017-5079-2","volume":"28","author":"JM Winfield","year":"2018","unstructured":"Winfield JM, Poillucci G, Blackledge MD, et al. Apparent diffusion coefficient of vertebral haemangiomas allows differentiation from malignant focal deposits in whole-body diffusion-weighted MRI. Eur Radiol. 2018;28:1687\u201391. https:\/\/doi.org\/10.1007\/s00330-017-5079-2.","journal-title":"Eur Radiol"},{"key":"1635_CR47","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1007\/s00330-022-09007-8","volume":"33","author":"O Chiabai","year":"2022","unstructured":"Chiabai O, Van Nieuwenhove S, Vekemans M-C, et al. Whole-body MRI in oncology: can a single anatomic T2 Dixon sequence replace the combination of T1 and STIR sequences to detect skeletal metastasis and myeloma? Eur Radiol. 2022;33:244\u201357. https:\/\/doi.org\/10.1007\/s00330-022-09007-8.","journal-title":"Eur Radiol"},{"key":"1635_CR48","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1002\/mrm.24369","volume":"68","author":"HH Hu","year":"2012","unstructured":"Hu HH, B\u00f6rnert P, Hernando D, et al. ISMRM workshop on fat\u2013water separation: Insights, applications and progress in MRI. Magn Reson Med. 2012;68:378\u201388. https:\/\/doi.org\/10.1002\/mrm.24369.","journal-title":"Magn Reson Med"},{"key":"1635_CR49","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1148\/radiol.211388","volume":"304","author":"V Koutoulidis","year":"2022","unstructured":"Koutoulidis V, Terpos E, Papanikolaou N, et al. Comparison of MRI features of fat fraction and ADC for early treatment response assessment in participants with multiple myeloma. Radiology. 2022;304:137\u201344. https:\/\/doi.org\/10.1148\/radiol.211388.","journal-title":"Radiology"}],"container-title":["Japanese Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11604-024-01635-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11604-024-01635-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11604-024-01635-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T16:59:36Z","timestamp":1732640376000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11604-024-01635-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,1]]},"references-count":49,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["1635"],"URL":"https:\/\/doi.org\/10.1007\/s11604-024-01635-y","relation":{},"ISSN":["1867-1071","1867-108X"],"issn-type":[{"value":"1867-1071","type":"print"},{"value":"1867-108X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,1]]},"assertion":[{"value":"19 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethical approval not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Consent to participate was obtained.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}